News

doctor and vaccine updates

Johnson & Johnson COVID-19 Vaccine Updates

April 23, 2021, Johnson & Johnson COVID-19 Vaccine Updates, FDA and CDC Announcement: …

Read the full story

NBCA in Strategic Partnership to Address Health Disparities

The National Blood Clot Alliance is proud to be a partner in the Venous Thromboembolism …

Read the full story

Top Moments of 2020

This past year gave way to many notable moments for the National Blood Clot Alliance (NBCA), as …

Read the full story

NBCA Welcomes Traci Wilkes Smith, Esq. to its Board of Directors

Traci Wilkes Smith is the Senior Vice President of Broadcasters in the Client Representation …

Read the full story

Make the Choice to Stop the Clot®

Blood Clot Awareness Month 2020: A New Year, A New Decade, and A New Time to Raise Blood Clot …

Read the full story

NBCA Educational Materials Selected for Use in New Joint Commission Educational Effort

The National Blood Clot Alliance is honored to have its website, as well as several of its …

Read the full story

May e-Newsletter | Celebrate & Share During National Women’s Health Week

Join the National Blood Clot Alliance (NBCA) during National Women’s Health Week (NWHW), May …

Read the full story
FDA Approved

FDA Approves Andexxa®

NEW DRUG APPROVAL: The U.S. Food & Drug Administration (FDA) has granted Portola …

Read the full story

Celebrate & Share During National Women’s Health Week

Birth Control and Blood Clots: Know Your Risk There are more than 60 million women of …

Read the full story

New Thrombophilia Resource

NBCA recently updated information on its website about thrombophilia or genetic blood clotting …

Read the full story

Current News

The National Blood Clot Alliance Launches New Council for Emerging Researchers in Thrombosis (CERT)

FOR IMMEDIATE RELEASE: 07/28/2022   The National Blood Clot Alliance (NBCA), the nation’s leading nonprofit patient advocacy organization dedicated to…

The FUVID Study

The FUVID Study (Functional Characterization of Chronic Thromboembolic Venous Disease in Children) is currently open for enrollment to qualified participants.…